RocketTickers

Akorn Receives FDA Approval for Betamethasone Dipropionate Loti

Long
NASDAQ:AKRX   None
AKRX: Akorn, Inc.
2019-10-14 16:25:00
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.